Drug Body Controls Adulterated Sinus Infection Packages
- The Egyptian Medicine Authority (EMA) has issued a warning regarding counterfeit packaging of Deltaclav 457MG/5ml Powder, operation No.
- The EMA advises individuals who suspect they have obtained a counterfeit product to immediately contact the authority.
- The EMA clarified that this alert specifically pertains to the identified operation number and does not represent a general issue wiht the availability of Deltaclav.Pharmacists are encouraged to...
Alert: Counterfeit Deltaclav Antibiotic circulating in Egypt
Table of Contents
Updated October 1, 2025, at 4:34 PM GMT
Counterfeit Drug Identified
The Egyptian Medicine Authority (EMA) has issued a warning regarding counterfeit packaging of Deltaclav 457MG/5ml Powder, operation No. 251264, manufactured by Delta Pharma.The EMA detected commercial fraud involving imitation of the legitimate product.
What to Do If You Suspect a Counterfeit
The EMA advises individuals who suspect they have obtained a counterfeit product to immediately contact the authority. Reports can be made via the hotline 15301 or through the EMA’s official website: www.edaegypt.gov.eg.
The EMA clarified that this alert specifically pertains to the identified operation number and does not represent a general issue wiht the availability of Deltaclav.Pharmacists are encouraged to verify packaging, and consumers are advised to consult with their pharmacist if they have any concerns.
Deltaclav: Approved Uses
Deltaclav is a prescribed antibiotic used to treat a range of bacterial infections. Approved uses include lower respiratory infections, otitis media (middle ear infection), sinusitis, and bacterial urinary system infections.